Skip to content
HowShorted

HCW Biologics Inc. short interest in 2022

In 2022, HCW Biologics Inc.'s disclosed short interest ran from 0.36% of shares outstanding on 14 Jan 2022 to 0.05% on 30 Dec 2022, a change of -0.31 percentage points. The year's high was 0.36% on 14 Jan 2022 and its low 0.03% on 15 Jul 2022, averaging 0.09% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.82 days on 29 Jul 2022. Full history: HCW Biologics Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for HCW Biologics Inc. in 2022

2022 in figures

Start of year
0.36% (14 Jan 2022)
End of year
0.05% (30 Dec 2022)
Change
-0.31 pp
High
0.36% (14 Jan 2022)
Low
0.03% (15 Jul 2022)
Average
0.09%
Highest days to cover
4.82 (29 Jul 2022)
SEC filings marked
8

Every report in 2022

HCW Biologics Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20220.36%1.64
31 Jan 20220.22%1.00
15 Feb 20220.18%2.69
28 Feb 20220.12%1.71
15 Mar 20220.15%3.39
31 Mar 20220.13%1.00results (8-K), 10-K filed
14 Apr 20220.12%1.00
29 Apr 20220.08%1.83
13 May 20220.09%1.8710-Q filed, results (8-K)
31 May 20220.04%1.63
15 Jun 20220.04%1.00
30 Jun 20220.05%1.63
15 Jul 20220.03%1.00
29 Jul 20220.05%4.82
15 Aug 20220.04%1.0010-Q filed, results (8-K)
31 Aug 20220.03%1.00
15 Sep 20220.05%1.00
14 Oct 20220.06%1.00
31 Oct 20220.03%1.00
15 Nov 20220.04%1.0010-Q filed, results (8-K)
30 Nov 20220.07%1.54
15 Dec 20220.04%1.02
30 Dec 20220.05%1.00

See also: HCW Biologics Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.